| scholarly article | Q13442814 |
| P2093 | author name string | Multhaup G | |
| Kloetzel PM | |||
| Koszinowski UH | |||
| Hengel H | |||
| Ruppert T | |||
| Boes B | |||
| P2860 | cites work | The primary structures of four subunits of the human, high-molecular-weight proteinase, macropain (proteasome), are distinct but homologous | Q24322953 |
| High resolution two-dimensional electrophoresis of proteins | Q24608190 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Alternative exon usage and processing of the major histocompatibility complex-encoded proteasome subunits | Q28202082 | ||
| A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC | Q28235385 | ||
| Second proteasome-related gene in the human MHC class II region | Q28235438 | ||
| Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene | Q28249670 | ||
| Regulation of gene expression of proteasomes (multi-protease complexes) during growth and differentiation of human hematopoietic cells | Q28264349 | ||
| Proteasomes: protein and gene structures | Q36090371 | ||
| Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway | Q36713254 | ||
| The mechanism and functions of ATP-dependent proteases in bacterial and animal cells | Q36736334 | ||
| Proteasomes are regulated by interferon gamma: implications for antigen processing | Q37036033 | ||
| The multicatalytic proteinase complex, a major extralysosomal proteolytic system | Q37901108 | ||
| Electron microscopy and image analysis of the multicatalytic proteinase | Q39272561 | ||
| Proteasomes: multicatalytic proteinase complexes | Q40486138 | ||
| Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes | Q41527048 | ||
| In vivo function of the proteasome in the ubiquitin pathway | Q41531854 | ||
| The major-histocompatibility-complex-encoded beta-type proteasome subunits LMP2 and LMP7. Evidence that LMP2 and LMP7 are synthesized as proproteins and that cellular levels of both mRNA and LMP-containing 20S proteasomes are differentially regulate | Q41533729 | ||
| Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules | Q41594402 | ||
| Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation | Q41594408 | ||
| Efficient processing of an antigenic sequence for presentation by MHC class I molecules depends on its neighboring residues in the protein | Q41665138 | ||
| Cell-specific accumulation of Drosophila proteasomes (MCP) during early development | Q42082451 | ||
| Molecular interaction of the proteasome (multicatalytic proteinase). Evidence that the proteasome is not a constituent of the ‘26 S’ multienzyme complex | Q42161763 | ||
| The high molecular weight multicatalytic proteinase, macropain, exists in a latent form in human erythrocytes | Q42203334 | ||
| Activation of the multicatalytic proteinase from rat skeletal muscle by fatty acids or sodium dodecyl sulphate | Q42849663 | ||
| Redistribution of critical major histocompatibility complex and T cell receptor-binding functions of residues in an antigenic sequence after biterminal substitution | Q43986747 | ||
| Primary structure of the Thermoplasma proteasome and its implications for the structure, function, and evolution of the multicatalytic proteinase | Q44722342 | ||
| Structural and serological similarity of MHC-linked LMP and proteasome (multicatalytic proteinase) complexes | Q44945274 | ||
| Subunit of the '20S' proteasome (multicatalytic proteinase) encoded by the major histocompatibility complex | Q45806302 | ||
| PRE2, highly homologous to the human major histocompatibility complex-linked RING10 gene, codes for a yeast proteasome subunit necessary for chrymotryptic activity and degradation of ubiquitinated proteins | Q48129568 | ||
| The proteasome of Drosophila and features of the evolutionarily conserved PROS-gene family | Q52446179 | ||
| The 19S ring-type particles of Drosophila. Cytological and biochemical analysis of their intracellular association and distribution. | Q52452023 | ||
| The Drosophila proteasome undergoes changes in its subunit pattern during development. | Q52452727 | ||
| A pentapeptide as minimal antigenic determinant for MHC class I-restricted T lymphocytes. | Q52538972 | ||
| Expression of functional Thermoplasma acidophilum proteasomes in Escherichia coli. | Q54668957 | ||
| The 22 S cylinder particles of Xenopus laevis. I. Biochemical and electron microscopic characterization | Q58439340 | ||
| MHC-linked LMP gene products specifically alter peptidase activities of the proteasome | Q59088266 | ||
| The proteasome/multicatalytic-multifunctional proteinase. In vivo function in the ubiquitin-dependent N-end rule pathway of protein degradation in eukaryotes | Q67492448 | ||
| A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation | Q70458585 | ||
| The multicatalytic proteinase complex (proteasome) and intracellular protein degradation: diverse functions of an intracellular particle | Q72949360 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | proteolysis | Q33123 |
| P304 | page(s) | 901-909 | |
| P577 | publication date | 1994-03-01 | |
| P1433 | published in | Journal of Experimental Medicine | Q3186912 |
| P1476 | title | Interferon gamma stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasomes | |
| P478 | volume | 179 |
| Q71034446 | 20S proteasome from LMP7 knock out mice reveals altered proteolytic activities and cleavage site preferences |
| Q57297283 | A Marine Diterpenoid Modulates the Proteasome Activity in Murine Macrophages Stimulated with LPS |
| Q57168094 | A Single Residue Exchange Within a Viral CTL Epitope Alters Proteasome-Mediated Degradation Resulting in Lack of Antigen Presentation |
| Q36960167 | A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction |
| Q28292545 | A protein related to a proteasomal subunit binds to the intracellular domain of the p55 TNF receptor upstream to its 'death domain' |
| Q38357921 | A role for the proteasome regulator PA28alpha in antigen presentation |
| Q53007185 | A third interferon-gamma-induced subunit exchange in the 20S proteasome. |
| Q42816220 | Abnormal IFN-gamma-dependent immunoproteasome modulation by Trypanosoma cruzi-infected macrophages |
| Q52508504 | Altered peptidase and viral-specific T cell response in LMP2 mutant mice. |
| Q23911143 | Altered properties of the branched chain amino acid-preferring activity contribute to increased cleavages after branched chain residues by the "immunoproteasome." |
| Q44104936 | Analysis of proteasome generated antigenic peptides by mass spectrometry |
| Q36398857 | Analysis of the expression of peptide-major histocompatibility complexes using high affinity soluble divalent T cell receptors |
| Q34801818 | Antigen degradation or presentation by MHC class I molecules via classical and non-classical pathways |
| Q24675502 | Antigen processing in vivo and the elicitation of primary CTL responses |
| Q45918640 | Antitopes define preferential proteasomal cleavage site usage. |
| Q44021101 | Assessment of proteasomal cleavage probabilities from kinetic analysis of time-dependent product formation |
| Q34161423 | Beta 2 subunit propeptides influence cooperative proteasome assembly |
| Q48708926 | Bovine spleen multicatalytic proteinase complex (proteasome). Replacement of X, Y, and Z subunits by LMP7, LMP2, and MECL1 and changes in properties and specificity |
| Q42824271 | Branched-chain-amino-acid-preferring peptidase activity of the lobster multicatalytic proteinase (proteasome) and the degradation of myofibrillar proteins |
| Q37698282 | CD8(+) T Cell Responses to Plasmodium and Intracellular Parasites |
| Q42206015 | Cell type-specific proteasomal processing of HIV-1 Gag-p24 results in an altered epitope repertoire |
| Q45084481 | Characterization and mapping of the gene encoding mouse proteasome subunit DELTA (Lmp19). |
| Q52914124 | Comparative expression analysis and characterization of 20S proteasomes in human intestinal tissues: The proteasome pattern as diagnostic tool for IBD patients. |
| Q24336801 | Constitutive and interferon-gamma-induced expression of the human proteasome subunit multicatalytic endopeptidase complex-like 1 |
| Q45733325 | Contribution of HLA class I allele expression to CD8+ T-cell responses against Epstein-Barr virus |
| Q77172034 | Contribution of proline residue for efficient production of MHC class I ligands by proteasomes |
| Q36364703 | Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter |
| Q71254579 | Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands |
| Q33683381 | Cytomegaloviral control of MHC class I function in the mouse. |
| Q78083121 | DNA immunization is associated with increased activity of type I iodothyronine 5'-deiodinase in mouse liver |
| Q28586982 | DUB-2 is a member of a novel family of cytokine-inducible deubiquitinating enzymes |
| Q36678563 | Decrypting the structure of major histocompatibility complex class I-restricted cytotoxic T lymphocyte epitopes with complex peptide libraries |
| Q41594000 | Delivery of antigens to the MHC class I pathway using bacterial toxins |
| Q42220600 | Designing the epitope flanking regions for optimal generation of CTL epitopes. |
| Q42067000 | Developmental changes of the 26 S proteasome in abdominal intersegmental muscles of Manduca sexta during programmed cell death. |
| Q62856559 | Differences in Catalytic Activities and Subunit Pattern of Multicatalytic Proteinase Complexes (Proteasomes) Isolated from Bovine Pituitary, Lung, and Liver |
| Q47954784 | Different requirements for signal transducer and activator of transcription 1alpha and interferon regulatory factor 1 in the regulation of low molecular mass polypeptide 2 and transporter associated with antigen processing 1 gene expression |
| Q40859882 | Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28 |
| Q32067271 | Differential processing of class-I-restricted epitopes by the standard proteasome and the immunoproteasome |
| Q30685494 | Discrete cleavage motifs of constitutive and immunoproteasomes revealed by quantitative analysis of cleavage products |
| Q36909248 | Diversity of proteasomal missions: fine tuning of the immune response |
| Q41006554 | Dynamics of proteasome distribution in living cells |
| Q41421759 | Effect of interferon-gamma on antigen processing in human monocytes |
| Q37711312 | Effects of ethanol on the proteasome interacting proteins |
| Q34782453 | Effects of interferon gamma and major histocompatibility complex-encoded subunits on peptidase activities of human multicatalytic proteases |
| Q41238854 | Effects of major-histocompatibility-complex-encoded subunits on the peptidase and proteolytic activities of human 20S proteasomes. Cleavage of proteins and antigenic peptides |
| Q36375899 | Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes |
| Q38305306 | Efficient identification of novel HLA-A(*)0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis. |
| Q41005864 | Efficient induction of cytotoxic CD8+ T cells against exogenous proteins: establishment and characterization of a T cell line specific for the membrane protein ActA of Listeria monocytogenes. |
| Q37989860 | Emerging roles of immunoproteasomes beyond MHC class I antigen processing |
| Q24679238 | Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity |
| Q60073956 | Erratum: γ-lnterferon and expression of MHC genes regulate peptide hydrolysis by proteasomes |
| Q37787891 | Feedback regulation of proteasome gene expression and its implications in cancer therapy |
| Q30452642 | Functional analysis of amino acid residues encompassing and surrounding two neighboring H-2Db-restricted cytotoxic T-lymphocyte epitopes in simian virus 40 tumor antigen |
| Q41722133 | Generation and TAP-mediated transport of peptides for major histocompatibility complex class I molecules. |
| Q35821221 | Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII. |
| Q30983359 | Global analysis of proteasomal substrate specificity using positional-scanning libraries of covalent inhibitors. |
| Q41533232 | Human Tumor Antigens and Cancer Immunotherapy |
| Q28284947 | Human lymphoblast and erythrocyte multicatalytic proteases: differential peptidase activities and responses to the 11S regulator |
| Q37727601 | IFN-γ directly controls IL-33 protein level through a STAT1- and LMP2-dependent mechanism |
| Q33753870 | Immune and myodegenerative pathomechanisms in inclusion body myositis |
| Q60384406 | Immune responses after immunization with plasmid DNA encoding Bet v 1, the major allergen of birch pollen |
| Q71564084 | Immunogenicity and immunosensitivity of ex vivo human carcinomas: interferon gamma and tumour necrosis factor alpha treatment of tumour cells potentiates their interaction with autologous blood lymphocytes |
| Q36381008 | Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits |
| Q34018605 | Immunoproteasome deficiency alters retinal proteasome's response to stress |
| Q46132051 | Immunoproteasome functions explained by divergence in cleavage specificity and regulation. |
| Q45131491 | Immunoproteasome subunit deficiencies impact differentially on two immunodominant influenza virus-specific CD8+ T cell responses |
| Q28285019 | In vivo assembly of the proteasomal complexes, implications for antigen processing |
| Q41034976 | Inactivation of a defined active site in the mouse 20S proteasome complex enhances major histocompatibility complex class I antigen presentation of a murine cytomegalovirus protein. |
| Q71815183 | Incorporation of major histocompatibility complex – encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon‐γ |
| Q54451070 | Increased proteasome-mediated degradation of occludin in irritable bowel syndrome. |
| Q34574839 | Inhibitor-binding mode of homobelactosin C to proteasomes: new insights into class I MHC ligand generation |
| Q34329553 | Innate and acquired immunity intersect in a global view of the acute-phase response |
| Q44569024 | Interferon gamma enhances proteasome activity in recombinant Hep G2 cells that express cytochrome P4502E1: modulation by ethanol |
| Q40915804 | Interferon regulatory factor 1 mediates the interferon-gamma induction of the human immunoproteasome subunit multicatalytic endopeptidase complex-like 1. |
| Q36266425 | Interferon-gamma, the functional plasticity of the ubiquitin-proteasome system, and MHC class I antigen processing |
| Q28207081 | Interferon-γ: an overview of signals, mechanisms and functions |
| Q34012443 | Interferons and interferon regulatory factors in malaria |
| Q33887390 | Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor beta subunits |
| Q40851962 | Kinetic evidences for facilitation of peptide channelling by the proteasome activator PA28. |
| Q36366222 | LMP-associated proteolytic activities and TAP-dependent peptide transport for class 1 MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12. |
| Q41109895 | Lactacystin and clasto-lactacystin beta-lactone modify multiple proteasome beta-subunits and inhibit intracellular protein degradation and major histocompatibility complex class I antigen presentation |
| Q41867663 | Link between organ-specific antigen processing by 20S proteasomes and CD8(+) T cell-mediated autoimmunity |
| Q37470941 | Molecular alterations in proteasomes of rat liver during aging result in altered proteolytic activities |
| Q48050255 | Molecular cloning of the mouse proteasome subunits MC14 and MECL-1: reciprocally regulated tissue expression of interferon-gamma-modulated proteasome subunits |
| Q37610453 | Molecular mechanisms of IFN-gamma to up-regulate MHC class I antigen processing and presentation |
| Q40940981 | Mutational analysis of subunit i beta2 (MECL-1) demonstrates conservation of cleavage specificity between yeast and mammalian proteasomes. |
| Q47285155 | Natural selection during functional divergence to LMP7 and proteasome subunit X (PSMB5) following gene duplication |
| Q24322943 | Newly identified pair of proteasomal subunits regulated reciprocally by interferon gamma |
| Q35025834 | On the role of proteasomes in cell biology and proteasome inhibition as a novel frontier in the development of immunosuppressants |
| Q35088241 | Ongoing coxsackievirus myocarditis is associated with increased formation and activity of myocardial immunoproteasomes |
| Q39584224 | PA28 and the proteasome immunosubunits play a central and independent role in the production of MHC class I-binding peptides in vivo |
| Q35772675 | Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. |
| Q35641485 | Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1. |
| Q58322277 | Phylogenic relationships of the amino acid sequences of prosome (proteasome, MCP) subunits |
| Q36380352 | Potential immunocompetence of proteolytic fragments produced by proteasomes before evolution of the vertebrate immune system |
| Q28303629 | Primary structures of two homologous subunits of PA28, a gamma-interferon-inducible protein activator of the 20S proteasome |
| Q83326201 | Priming of Leishmania-reactive CD8+ T cells in vivo does not require LMP7-containing immunoproteasomes |
| Q36104480 | Proapoptotic regimes for HTLV-I-transformed cells: targeting Tax and the NF-kappaB pathway |
| Q41053715 | Processing and delivery of peptides presented by MHC class I molecules |
| Q35079913 | Progression of cancer from indolent to aggressive despite antigen retention and increased expression of interferon-gamma inducible genes |
| Q40416410 | Proteasome and class I antigen processing and presentation |
| Q28305317 | Proteasome components with reciprocal expression to that of the MHC-encoded LMP proteins |
| Q50077966 | Proteasome dysregulation in human cancer: implications for clinical therapies |
| Q34362098 | Proteasome functioning in breast cancer: connection with clinical-pathological factors |
| Q78169885 | Proteasome participates in the alteration of signal transduction in T and B lymphocytes following trauma-hemorrhage |
| Q38269935 | Proteasome subtypes and regulators in the processing of antigenic peptides presented by class I molecules of the major histocompatibility complex |
| Q33264524 | Proteasome-mediated degradation of IkappaBalpha and processing of p105 in Crohn disease and ulcerative colitis |
| Q47098533 | Proteasomes in Protein Homeostasis of Pluripotent Stem Cells |
| Q53354360 | Proteasomes in immune cells: more than peptide producers? |
| Q71980463 | Proteasomes. Complex proteases lead to a new understanding of cellular regulation through proteolysis |
| Q34700398 | Protein degradation and the generation of MHC class I-presented peptides. |
| Q33815369 | Proteolysis and class I major histocompatibility complex antigen presentation |
| Q47916219 | Rapid degradation of solid-phase bound peptides by the 20S proteasome |
| Q52199698 | Regulation of LMP2 and TAP1 genes by IRF-1 explains the paucity of CD8+ T cells in IRF-1-/- mice. |
| Q45785307 | Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression |
| Q77420527 | Selective proteasome inhibitors: modulators of antigen presentation? |
| Q40027466 | Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits |
| Q99631248 | Serum 20S proteasome levels are associated with disease activity in MPO-ANCA-associated microscopic polyangiitis |
| Q71824471 | Specific inhibition of the chymotrypsin-like activity of the proteasome induces a bipolar morphology in neuroblastoma cells |
| Q37798615 | Structure, Assembly and Homeostatic Regulation of the 26S Proteasome |
| Q24537252 | Subcellular recruitment of fibrillarin to nucleoplasmic proteasomes: implications for processing of a nucleolar autoantigen |
| Q28567694 | Subtypes of 20S proteasomes from skeletal muscle |
| Q24311953 | Subunit arrangement in the human 20S proteasome |
| Q92150684 | Synthesis and Application of an Activity-Based Peptide-Peptoid Hybrid Probe for the Immunoproteasome |
| Q47700046 | The MHC class I ligand-generating system: roles of immunoproteasomes and the interferon-gamma-inducible proteasome activator PA28. |
| Q41862238 | The Ubiquitin-Proteasome System in Huntington's Disease: Are Proteasomes Impaired, Initiators of Disease, or Coming to the Rescue? |
| Q27939678 | The active sites of the eukaryotic 20 S proteasome and their involvement in subunit precursor processing |
| Q34956064 | The cell-mediated immune response to human papillomavirus-induced cervical cancer: implications for immunotherapy. |
| Q42943174 | The cleavage preference of the proteasome governs the yield of antigenic peptides. |
| Q64166842 | The immunoproteasome and thymoproteasome: functions, evolution and human disease |
| Q37393379 | The immunoproteasome as a target in hematologic malignancies |
| Q41952815 | The immunoproteasome in steatohepatitis: its role in Mallory-Denk body formation |
| Q33796158 | The proteasome activator 11 S REG (PA28) and class I antigen presentation |
| Q33673764 | The proteasome complex and the maintenance of pluripotency: sustain the fate by mopping up? |
| Q30453898 | The proteolytic fragments generated by vertebrate proteasomes: structural relationships to major histocompatibility complex class I binding peptides |
| Q24799415 | The role of major histocompatibility complex molecules in luteal function |
| Q28219263 | The role of the proteasome activator PA28 in MHC class I antigen processing |
| Q37851052 | The role of the proteasome in the generation of MHC class I ligands and immune responses |
| Q36401780 | The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope |
| Q33815363 | The specificity of proteasomes: impact on MHC class I processing and presentation of antigens |
| Q29618194 | The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B |
| Q36364985 | Theiler's virus infection of 129Sv mice that lack the interferon alpha/beta or interferon gamma receptors |
| Q36364157 | Trimming of antigenic peptides in an early secretory compartment |
| Q35154144 | Trypanosoma cruzi infection down-modulates the immunoproteasome biosynthesis and the MHC class I cell surface expression in HeLa cells |
| Q41292381 | Tumour-infiltrating lymphocytes mediate lysis of autologous squamous cell carcinomas of the head and neck |
| Q36597620 | Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide |
| Q34010999 | Upregulation of immunoproteasome subunits in myositis indicates active inflammation with involvement of antigen presenting cells, CD8 T-cells and IFNΓ |
| Q34465970 | Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland |
| Q27491004 | What is the role of alternate splicing in antigen presentation by major histocompatibility complex class I molecules? |
Search more.